other material
confidence high
sentiment neutral
materiality 0.65
Myriad Genetics raises ~$110M via public offering of 6.47M shares at $17/sh
MYRIAD GENETICS INC
- Entered underwriting agreement with Goldman Sachs, Morgan Stanley, and Wells Fargo to sell 6,470,588 shares at $17.00/share.
- Underwriters have a 30-day option to purchase up to 970,588 additional shares.
- Offering closed on November 13, 2023; net proceeds after underwriting discounts and commissions not specified.
- Prospectus supplement filed under automatic shelf registration statement (File No. 333-275396).